Funded Tech Companies
NKT Therapeutics
Wondering who backed NKT Therapeutics? SV Health Investors, private investors and MedImmune Ventures put venture money into this biopharmaceutical company.
Company Overview
Company Name
NKT Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
58 Deborah Sampson St.
Sharon, MA 02067
USA
Sharon, MA 02067
USA
Phone
Website
Email Address
Company Background Information
Overview
NKT Therapeutics, Inc. is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Mashal
Chief Scientific Officer
Robert Schaub
VP - Finance
Ron Goldstein
Company Investors
- SV Health Investors (Michael Ross)
- MedImmune Ventures (Joseph Amprey)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs